peptidesciences.com retatrutide Vial of unapproved peptide retatrutide

Tirzepatide results timeline Tirzepatide (brand name Mounjaro for diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist

Trends Cardiovasc Med

While GLP-1 suppresses appetite and slows gastric emptying, GIP enhances insulin secretion and possibly changes how the body uses fat, and glucagon increases energy expenditure and promotes fat breakdown

With the rising incidence of obesity, there is a growing demand for new therapies which can effectively manage body weight and improve health

The universe, am I right

This product is not a drug, food or cosmetic and may not be misbranded, mislabeled or misused as such